TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18639205

Group type: EXPERIMENTAL
Intervention: Blunt needles
Number of subjects: 438

Group type: COMPARATOR
Intervention: Sharp needles
Number of subjects: 438
Study: 14594860

Group type: EXPERIMENTAL
Intervention: +GH (0.4 IU GH)
Number of subjects: 8

Group type: COMPARATOR
Intervention: -GH
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (healthy subjects, n = 8, mean age = 40.4 +/- 4.2 yr)
Number of subjects: 8
Study: 12678539

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate ointment (0.2% twice daily) applied to the perianal area
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo ointment applied to the perianal area
Number of subjects: 20
Study: 9743392

Group type: EXPERIMENTAL
Intervention: Atipamezole 15 microg/kg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Atipamezole 50 microg/kg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Atipamezole 150 microg/kg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 14
Study: 11271207

Group type: EXPERIMENTAL
Intervention: FK 506
Number of subjects: 540
Study: 3191944

Group type: EXPERIMENTAL
Intervention: Sertraline 25 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sertraline 50 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sertraline 75 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sertraline 100 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31841037

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation during exercise sessions
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham transcutaneous electrical nerve stimulation during exercise sessions
Number of subjects: 18
Study: 31707824

Group type: EXPERIMENTAL
Intervention: High ordering cardiologists (top tertile of transthoracic echocardiograms)
Number of subjects: 3966

Group type: COMPARATOR
Intervention: Low ordering cardiologists (low tertile of transthoracic echocardiograms)
Number of subjects: 3966
Study: 28855179

Group type: EXPERIMENTAL
Intervention: LBNP+FC (face cooling with ice water at 0±0°C)
Number of subjects: 10

Group type: COMPARATOR
Intervention: LBNP+Sham (thermoneutral water at 34±1°C)
Number of subjects: 10
Study: 25457977

Group type: EXPERIMENTAL
Intervention: Chiropractic manipulative therapy (MT) plus rehabilitation
Number of subjects: 33

Group type: COMPARATOR
Intervention: Rehabilitation alone
Number of subjects: 33
Study: 23237514

Group type: EXPERIMENTAL
Intervention: Anti-stretch mark cream containing hydroxyprolisilane-C, rosehip oil, Centella asiatica triterpenes and vitamin E
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (cream without active ingredients)
Number of subjects: 100
Study: 21529979

Group type: EXPERIMENTAL
Intervention: Routine Glutamic Acid Decarboxylase Antibody (GADA) testing
Number of subjects: 0
Study: 19896601

Group type: EXPERIMENTAL
Intervention: Suction curettage
Number of subjects: 1320

Group type: COMPARATOR
Intervention: Conventional procedure
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: Suction curettage and Conventional procedure
Number of subjects: 1320
Study: 16823248

Group type: EXPERIMENTAL
Intervention: Carvedilol (12.5 mg/day for the first 2 days, then 25 mg/day for 90 days)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Atenolol (50 mg/day for 90 days)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Doxazosin (2 mg/day for 90 days)
Number of subjects: 77
Study: 12764341

Group type: COMPARATOR
Intervention: Prochlorperazine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sodium valproate
Number of subjects: 40
Study: 10799347

Group type: COMPARATOR
Intervention: 500 mg valerian and 120 mg hops (low dosage)
Number of subjects: 12

Group type: COMPARATOR
Intervention: 1500 mg valerian and 360 mg hops (high dosage)
Number of subjects: 12
Study: 9404921

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (busulfan 16 mg/kg, etoposide 40 mg/kg, cytosine arabinoside 3 g/m2 x 4) followed by autologous peripheral blood stem cell transplantation (ABSCT) in 13 patients.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF) administered concurrently with the BEA regimen during conditioning in 47 patients.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Not applicable (patients in relapse).
Number of subjects: 60

Group type: COMPARATOR
Intervention: Not applicable (control group not specified).
Number of subjects: 60
Study: 8362632

Group type: EXPERIMENTAL
Intervention: Erythromycin (1000 mg/day for 10 days) in Group A
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Roxithromycin (300 mg/day for 10 days) in Group B
Number of subjects: 62

Group type: COMPARATOR
Intervention: Erythromycin (1 g/day for 14 days) in Group C
Number of subjects: 62
Study: 3750135

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl 100 micrograms postoperatively
Number of subjects: 61

Group type: COMPARATOR
Intervention: Intramuscular pethidine 1.5 mg/kg 4‐6‐hourly as required
Number of subjects: 61
Study: 30092092

Group type: EXPERIMENTAL
Intervention: Multimodal training (balance and fine hand exercises)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Treadmill training (weight‐supported robotic‐assisted)
Number of subjects: 21
Study: 27363518

Group type: EXPERIMENTAL
Intervention: Fatty fish (750 g/week)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Lean fish (750 g/week)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Lean meat (control)
Number of subjects: 38
Study: 24886338

Group type: EXPERIMENTAL
Intervention: Epley's maneuver
Number of subjects: 49400

Group type: COMPARATOR
Intervention: Sham maneuver
Number of subjects: 49400
Study: 23045213

Group type: EXPERIMENTAL
Intervention: RBCs stored for 7 days or less (n = 188)
Number of subjects: 377

Group type: COMPARATOR
Intervention: Standard-issue RBCs (n = 189)
Number of subjects: 377
Study: 20229000

Group type: EXPERIMENTAL
Intervention: Midazolam 0.2 mg kg(‐1) (small-dose group, n = 12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Midazolam 0.3 mg kg(‐1) (large-dose group, n = 12)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both doses of midazolam (0.2 and 0.3 mg kg(‐1))
Number of subjects: 24
Study: 18520802

Group type: EXPERIMENTAL
Intervention: PPX/carboplatin (PPX 210 mg/m/10 min without routine steroid premedication)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Paclitaxel/carboplatin (Paclitaxel 225 mg/m/3 h with standard premedication)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: PPX/carboplatin
Number of subjects: 400

Group type: COMPARATOR
Intervention: Paclitaxel/carboplatin
Number of subjects: 400
Study: 15249792

Group type: EXPERIMENTAL
Intervention: DASH diet with higher sodium intake (142 mmol/d)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: DASH diet with lower sodium intake (65 mmol/d)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Typical American diet with higher sodium intake (142 mmol/d)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Typical American diet with lower sodium intake (65 mmol/d)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Typical American diet with intermediate sodium intake (107 mmol/d)
Number of subjects: 100
Study: 11733659

Group type: EXPERIMENTAL
Intervention: Sevoflurane (0.4 minimum alveolar concentration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Isoflurane (0.4 minimum alveolar concentration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 0

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 0
Study: 9310093

Group type: EXPERIMENTAL
Intervention: Tai Chi (TC)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Individualized balance training (BT)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Exercise control education (ED)
Number of subjects: 130
Study: 8393685

Group type: EXPERIMENTAL
Intervention: Lisinopril (10 mg/day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 3526617

Group type: EXPERIMENTAL
Intervention: Corinfar administered sublingually at a dose of 10-30 mg
Number of subjects: 0
Study: 31262371

Group type: EXPERIMENTAL
Intervention: 4 g n‐3 PUFA daily for 3 months
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 4 g n‐3 PUFA daily for 3 months (after washout)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (after washout)
Number of subjects: 70
Study: 29141712

Group type: COMPARATOR
Intervention: Continuous ART (C-ART)
Number of subjects: 632

Group type: EXPERIMENTAL
Intervention: Structured ART interruptions (2/4-ART)
Number of subjects: 632

Group type: EXPERIMENTAL
Intervention: CD4-guided ART interruptions (CD4GT)
Number of subjects: 632

Group type: EXPERIMENTAL
Intervention: Bacterial infections
Number of subjects: 632

Group type: EXPERIMENTAL
Intervention: Non-HIV-related morbidity
Number of subjects: 632
Study: 27337606

Group type: EXPERIMENTAL
Intervention: Incremental inspiratory threshold loading
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Elbow flexor loading
Number of subjects: 15
Study: 24686130

Group type: EXPERIMENTAL
Intervention: DASH diet
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual dietary advice (UDA)
Number of subjects: 60
Study: 22523305

Group type: EXPERIMENTAL
Intervention: Conventional coronary artery bypass grafting
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Off-pump coronary artery bypass grafting (OPCAB)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 900
Study: 19232601

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle exercises (PFME) alone
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: PFME combined with biofeedback
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: PFME combined with electrical stimulation
Number of subjects: 32
Study: 17890476

Group type: EXPERIMENTAL
Intervention: fenoterol (200 microg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ipratropium bromide (40 microg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 60
Study: 15372589

Group type: EXPERIMENTAL
Intervention: entacapone 200 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: entacapone 400 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: entacapone (200 mg and 400 mg)
Number of subjects: 0
Study: 11203847

Group type: EXPERIMENTAL
Intervention: Amalgam core build-ups (Duralloy, Degussa Ltd, Cheshire, UK)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hybrid composite material
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cermet material (Ketac-Silver, ESPE GmbH, Seefeld, Germany)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Resin-composite materials (prisma APH, Ti-Core, Coradent)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Core build-ups (all materials) after crown preparation
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Amalgam core build-ups after crown preparation
Number of subjects: 10
Study: 9347122

Group type: EXPERIMENTAL
Intervention: d-amphetamine (0.25 mg/kg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 8442592

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen (O2)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Air (control)
Number of subjects: 14
Study: 3510594

Group type: EXPERIMENTAL
Intervention: Cold potassium cardioplegia with St. Thomas' Hospital solution (Group 1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intermittent ischemic arrest (Group 2)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cold potassium cardioplegia (Group 1)
Number of subjects: 30
Study: 31006007

Group type: EXPERIMENTAL
Intervention: n-3 PUFAs (EPA and DHA) at doses reflecting 1, 2, or 4 portions of oily fish per week (3.27 g EPA + DHA per portion)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: n-3 PUFAs (EPA and DHA)
Number of subjects: 121
Study: 29664955

Group type: EXPERIMENTAL
Intervention: Biomechanically-based yoga exercise (YE)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Traditional exercise (TE)
Number of subjects: 31

Group type: COMPARATOR
Intervention: No-exercise attention-equivalent control (NE)
Number of subjects: 31
Study: 28671082

Group type: EXPERIMENTAL
Intervention: Zhuang medicine medicated thread moxibustion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pre-treatment group
Number of subjects: 60
Study: 26180248

Group type: EXPERIMENTAL
Intervention: Sweet pudding
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bitter pudding
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control pudding
Number of subjects: 20
Study: 24012033

Group type: EXPERIMENTAL
Intervention: Intravenous enoxaparin
Number of subjects: 910

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 910
Study: 21127284

Group type: EXPERIMENTAL
Intervention: 5 mg levobupivacaine + 10 μg fentanyl
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 4 mg levobupivacaine + 10 μg fentanyl
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 3 mg levobupivacaine + 10 μg fentanyl
Number of subjects: 90
Study: 19068600

Group type: EXPERIMENTAL
Intervention: Anterior approach osteotomy, iliac bone graft and internal fixation (Group A)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Transpedicular posterior decompression and internal fixation (Group B)
Number of subjects: 34
Study: 16820547

Group type: EXPERIMENTAL
Intervention: Varenicline (1 mg twice daily, n = 344)
Number of subjects: 1027

Group type: EXPERIMENTAL
Intervention: Bupropion SR (150 mg twice daily, n = 342)
Number of subjects: 1027

Group type: COMPARATOR
Intervention: Placebo (n = 341)
Number of subjects: 1027
Study: 12715635

Group type: EXPERIMENTAL
Intervention: Hypertensive type II diabetes mellitus
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Normotensive type II diabetes mellitus
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy control
Number of subjects: 30
Study: 10886201

Group type: EXPERIMENTAL
Intervention: 0.5 mg intravenous vitamin K
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1 mg intravenous vitamin K
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 2 mg intravenous vitamin K
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study: 9039339

Group type: EXPERIMENTAL
Intervention: Oral oestrogen replacement therapy (17 beta-oestradiol 2 mg daily on days 1-22 and 1 mg daily on days 23-28, norethisterone 1 mg days 13-22)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Transdermal oestrogen replacement therapy (oestradiol 50 micrograms/24 h on days 1-28, norethisterone 250 micrograms/24 h on days 15-28)
Number of subjects: 14
Study: 1554119

Group type: EXPERIMENTAL
Intervention: Transdermal 10% lidocaine gel with 3% glycyrrhetinic acid monohemiphthalate disodium (GAMHPh)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (Transdermal 10% lidocaine gel without GAMHPh)
Number of subjects: 24
Study: 30883268

Group type: EXPERIMENTAL
Intervention: Online patient simulation (OPS) in addition to training as usual (TAU)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Training as usual (TAU)
Number of subjects: 308
Study: 27246516

Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation programme combining multimodal exercises with psychologist‐lead cognitive‐behavioural therapy sessions
Number of subjects: 170

Group type: COMPARATOR
Intervention: General physiotherapy (control group)
Number of subjects: 170
Study: 25676529

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (with prestudy heparin)
Number of subjects: 8281

Group type: COMPARATOR
Intervention: Enoxaparin/VKA (with prestudy heparin)
Number of subjects: 8281

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (without prestudy heparin)
Number of subjects: 8281

Group type: COMPARATOR
Intervention: Enoxaparin/VKA (without prestudy heparin)
Number of subjects: 8281
Study: 24405575

Group type: EXPERIMENTAL
Intervention: Safety Management in Licensed Environments intervention delivered by Environmental Health Officers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 22871683

Group type: EXPERIMENTAL
Intervention: Vision-based tracking
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Haptics
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Passive exoskeleton
Number of subjects: 44
Study: 19251798

Group type: EXPERIMENTAL
Intervention: Autotitrating bilevel ventilator (AutoVPAP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard bilevel ventilator (VPAP III)
Number of subjects: 20
Study: 17999429

Group type: EXPERIMENTAL
Intervention: BTX‐B (20 U, 100 U, or 500 U/0.2 mL)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 16206608

Group type: EXPERIMENTAL
Intervention: Combined therapy (i.v. prospidin 200‐300 mg/week + i.m. methotrexate 10 mg/week)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Methotrexate monotherapy (10 mg/week i.m.)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Combined therapy
Number of subjects: 63

Group type: COMPARATOR
Intervention: Methotrexate monotherapy
Number of subjects: 63
Study: 11881901

Group type: EXPERIMENTAL
Intervention: Upright orientation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Inverted orientation
Number of subjects: 24
Study: 9924157

Group type: EXPERIMENTAL
Intervention: Video telecommunication network for transmitting coronary images during procedures
Number of subjects: 40
Study: 7477994

Group type: EXPERIMENTAL
Intervention: Low-dose oral prednisone (20 mg daily for the first week and 10 mg daily for the second week)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2142574

Group type: EXPERIMENTAL
Intervention: Gestodene and ethinyl estradiol (Femovan)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Desogestrel and ethinyl estradiol (Marvelon)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Single-dose ethinyl estradiol from Femovan
Number of subjects: 69

Group type: COMPARATOR
Intervention: Single-dose ethinyl estradiol from Marvelon
Number of subjects: 69
Study: 7421154

Group type: EXPERIMENTAL
Intervention: SPICAs (short versions of the Porch Index of Communicative Ability)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Standard PICA
Number of subjects: 93
Study: 29508532

Group type: EXPERIMENTAL
Intervention: Cardiovascular self-management support program (5A's self-management support program)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 12
Study: 28414857

Group type: EXPERIMENTAL
Intervention: External cephalic version (ECV) before term
Number of subjects: 1765

Group type: EXPERIMENTAL
Intervention: External cephalic version (ECV) before term with anterior placenta
Number of subjects: 1765
Study: 25872503

Group type: EXPERIMENTAL
Intervention: SMS text-based smoking cessation intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed/waiting list intervention control condition
Number of subjects: 0
Study: 23512951

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle modification (diet, exercise, weight loss)
Number of subjects: 3819

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 3819

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 3819
Study: 20619408

Group type: EXPERIMENTAL
Intervention: Early standard enteral nutrition (EN) provided within 24 hours of injury
Number of subjects: 126
Study: 19678952

Group type: EXPERIMENTAL
Intervention: 60 mg/kg human AAT (Prolastin) weekly infusions
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 17367973

Group type: EXPERIMENTAL
Intervention: Group 1 (5, 20, 45 s)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Group 2 (10, 25, 50 s)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Group 3 (15, 30, 55 s)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Injection protocol used in this study
Number of subjects: 128
Study: 15311314

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: SRP and 250 mg of metronidazole (3 times a day for 10 days)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Metronidazole alone
Number of subjects: 12
Study: 11333061

Group type: EXPERIMENTAL
Intervention: Biphasic waveform shocks (first shock 150 J, second shock 150 J if necessary)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Monophasic waveform shocks (first shock 150 J, second shock 360 J if necessary)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Monophasic waveform shocks
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Biphasic waveform shocks
Number of subjects: 57
Study: 9765722

Group type: EXPERIMENTAL
Intervention: Breast conservation therapy (lumpectomy with axillary dissection)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Modified radical mastectomy
Number of subjects: 7
Study: 7524997

Group type: EXPERIMENTAL
Intervention: T-TURP
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: M-TURP
Number of subjects: 167

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 167
Study: 3035002

Group type: EXPERIMENTAL
Intervention: Naloxone (2 mg i.v.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (i.v.)
Number of subjects: 0
Study: 29991053

Group type: EXPERIMENTAL
Intervention: Sucroferric Oxyhydroxide
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control
Number of subjects: 68
Study: 27185677

Group type: EXPERIMENTAL
Intervention: C‐MAC video laryngoscope
Number of subjects: 140

Group type: COMPARATOR
Intervention: Flexible fiberoptic scope (FFS)
Number of subjects: 140
Study: 25602163

Group type: EXPERIMENTAL
Intervention: TC-5214 (dexmecamylamine) adjunct therapy (0.5, 2 or 4 mg in Study 004; 0.1, 1 or 4 mg in Study 005)
Number of subjects: 1336

Group type: COMPARATOR
Intervention: Placebo adjunct therapy
Number of subjects: 1336
Study: 24006670

Group type: EXPERIMENTAL
Intervention: Transcutaneous acupoint electrical stimulation (TAES) combined with target controlled infusion of Propofol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (target controlled infusion of Propofol without TAES)
Number of subjects: 40
Study: 21911122

Group type: EXPERIMENTAL
Intervention: Laparoscopic bilateral nephrectomy (LBN)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Open bilateral nephrectomy (OBN)
Number of subjects: 66
Study: 18628529

Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 20